RA

Rosalind Advisors Portfolio holdings

AUM $207M
1-Year Est. Return 62.29%
This Quarter Est. Return
1 Year Est. Return
+62.29%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
29
New
Increased
Reduced
Closed

Top Buys

1 +$9.9M
2 +$9.62M
3 +$8.67M
4
XERS icon
Xeris Biopharma Holdings
XERS
+$8.33M
5
VRDN icon
Viridian Therapeutics
VRDN
+$7.85M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$9.9M 8.15%
+37,774
2
$9.62M 7.92%
+1,919,910
3
$8.67M 7.14%
+1,128,708
4
$8.33M 6.86%
+3,543,685
5
$7.85M 6.46%
+360,332
6
$6.99M 5.75%
+798,500
7
$6.3M 5.19%
+325,705
8
$6.17M 5.08%
+606,751
9
$5.78M 4.76%
+25,000
10
$5.56M 4.58%
+66,855
11
$5.54M 4.56%
+57,400
12
$4.97M 4.09%
+250,000
13
$4.65M 3.83%
+1,586,392
14
$4.53M 3.73%
+533,333
15
$4.32M 3.56%
+1,038,828
16
$3.67M 3.03%
+300,000
17
$2.88M 2.37%
+400,000
18
$2.6M 2.14%
+925,194
19
$2.5M 2.06%
+1,862,425
20
$2.12M 1.74%
+16,800
21
$1.83M 1.51%
+607,797
22
$1.6M 1.32%
+312,091
23
$1.01M 0.83%
+196,300
24
$805K 0.66%
+60,000
25
$558K 0.46%
+758,966